Status:
UNKNOWN
Efficacy of a Digestive Enzyme Blend
Lead Sponsor:
Deerland Enzymes
Collaborating Sponsors:
Kennesaw State University
Conditions:
Digestive Health
Indigestion
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the effect of a digestive enzyme supplement (three times per day for 30 days) on gastrointestinal distress (GID) and body composition (body mass and body fa...
Detailed Description
Pre-Screening: Subjects will first undergo a pre-screening visit with the PI. The PI will go over the COVID-19 screening as well as the study screening for inclusion and exclusion criteria. Subjects w...
Eligibility Criteria
Inclusion
- Be 18 - 55 years of age.
- Experience occasional gastrointestinal distress - 3 -6 episodes per month.
- Gastrointestinal distress may be defined as constipation, upset stomach, diarrhea, stomach cramping, bowel incontinence, heart-burn, acid reflux, gastroesophageal reflux, bloating or swelling of the belly, nausea or vomiting
Exclusion
- Currently taking prescription medications for gastrointestinal distress.
- Taking prescription medications that may be impacted by enzyme consumption.
- Taking steroidal medications.
- Currently ill. Have a diagnosed severe gastrointestinal disorder including: fissures, abscesses, or hemorrhoids.
- Have a greater than 30 kg/m2 BMI.
- Currently pregnant or attempting to get pregnant.
- Do not have access to a cell phone or computer daily.
- Are being treated by a clinician for GI disease.
Key Trial Info
Start Date :
May 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04917913
Start Date
May 10 2021
End Date
January 31 2022
Last Update
June 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kennesaw State University
Kennesaw, Georgia, United States, 30144